Axsome Therapeutics Ratios (2021-2026) | AXSM

Ratios Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter) 88.85%88.58%90.60%92.01%90.15%88.70%89.69%91.60%90.76%91.95%-2,002.80%91.94%91.04%93.03%93.71%92.30%
EBT Margin (Quarter) -469.82%-266.08%-251.29%-9.13%-145.15%-108.80%-138.37%-91.14%-91.03%-61.67%-14,965.40%-48.91%-32.61%-27.62%-14.35%-33.76%
EBIT Margin (Quarter) -444.23%-251.76%-245.86%-6.74%-139.31%-107.49%-137.39%-89.70%-89.54%-59.78%-14,523.40%-46.91%-24.47%-26.97%51.70%-33.14%
EBITDA Margin (Quarter) -444.23%-251.76%-245.86%-6.74%-139.31%-107.49%-137.39%-89.70%-89.54%-59.78%-14,523.40%-46.91%-24.47%-26.97%51.70%-33.14%
Operating Margin (Quarter) -444.23%-251.76%-245.86%-6.74%-139.31%-107.49%-137.39%-89.70%-89.54%-59.78%-14,523.40%-46.91%-24.47%-26.97%51.70%-33.14%
Net Margin (Quarter) -469.82%-266.08%-251.29%-11.88%-143.87%-107.62%-137.92%-91.14%-91.03%-61.67%-14,982.40%-48.91%-31.95%-27.62%-14.59%-33.76%
FCF Margin (Quarter) -382.97%-135.49%-113.84%-6.23%-118.81%-93.30%-42.46%-71.42%-34.60%-17.87%-5,246.40%-35.99%-21.62%0.58%-9.55%-10.89%
Efficiency
Inventory Average (Quarter) 12.16M9.15M6.13M8.60M9.62M12.56M15.36M15.40M14.74M15.00M16.03M17.38M21.11M25.86M29.73M
Assets Average (Quarter) 88.17M134.56M259.76M335.22M360.33M500.41M606.25M594.55M566.98M546.98M554.84M564.98M582.58M618.23M654.52M679.53M701.71M
Equity Average (Quarter) 15.16M14.95M86.28M133.46M110.68M195.31M274.16M230.24M167.51M123.44M97.88M74.96M55.11M63.14M73.40M81.01M71.44M
Invested Capital (Quarter) 65.63M64.70M110.20M252.36M204.56M261.81M458.80M449.51M370.98M324.04M282.85M172.90M237.01M233.21M193.07M193.73M208.29M65.74M
Asset Utilization Ratio (Quarter) 0.400.360.370.460.440.530.610.470.540.610.680.941.01
Leverage & Solvency
Debt to Equity (Quarter) 3.143.366.540.640.911.370.660.680.971.281.812.033.173.572.571.731.452.36
Debt Ratio (Quarter) 0.560.560.550.300.300.390.300.310.310.340.340.340.320.320.290.190.190.18
Equity Ratio (Quarter) 0.180.170.080.460.330.290.460.450.320.260.190.170.100.090.110.110.130.08
Valuation
Enterprise Value (Quarter) -86.47M-84.70M-73.39M-227.52M-200.84M-246.50M-437.11M-416.60M-386.19M-331.44M-315.66M-327.30M-315.35M-300.90M-303.02M-325.30M-322.93M-305.10M
Return Ratios
Return on Sales (Quarter) -0.05%-0.03%-0.03%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-1.50%0.00%0.00%0.00%0.00%0.00%
Return on Capital Employed (Quarter) -75.34%-56.95%-45.08%-39.36%-50.87%-69.21%-84.82%-85.38%-83.78%-79.80%-82.91%-72.20%-12.80%-17.09%
Return on Invested Capital (Quarter) -0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%0.00%
Return on Assets (Quarter) 0.00%-0.01%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter) -0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.02%-0.02%-0.03%-0.04%-0.05%-0.04%-0.03%-0.02%-0.03%